Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
| ▸ | CA9 | Q16790 | 2/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29669681 | 1.00 | CA1 (0.66) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL14015393 | 0.94 | CA1 (0.58) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL15903703 | 0.85 | GAA (0.49) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL28736563 | 0.84 | CA1 (0.61) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL8320952 | 0.83 | CA1 (0.70) | CA1CA2CA9TDP1L3MBTL1 | |
| Naphthalene SCHEMBL7767454 | 0.83 | CA1 (0.52) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL6214357 | 0.82 | KMT2A (0.65) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL11299892 | 0.82 | GAA (0.53) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL6209491 | 0.82 | KMT2A (0.59) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL11133857 | 0.81 | GAA (0.49) | CA1CA2CA9TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025065506-A1 | BENZYLAMINE COMPOUND, SYNTHESIS METHOD THEREFOR, AND USE THEREOF | 肇庆学院 | 2025-04-03 | — | — | WO | claimed |
| CN-119523898-A | Nasal administration preparation of multi-target medicine and application thereof | 肇庆学院 | 2025-02-28 | — | — | CN | claimed |
| WO-2022089499-A1 | PREFERRED METHOD OF USING LEVALBUTEROL SULFATE FOR THE TREATMENT OF RESPIRATORY DISEASES | 苏州君宁新药开发中心有限公司 | 2022-05-05 | — | — | WO | claimed |
| WO-2022057839-A1 | USE OF DRY POWDER INHALATION FORMULATION PREPARED FROM LEVOSALBUTAMOL SULFATE | 苏州君宁新药开发中心有限公司 | 2022-03-24 | — | — | WO | claimed |
| CN-108997261-B | Compound and preparation method and application thereof | 东莞市凯法生物医药有限公司 | 2022-01-07 | — | — | CN | claimed |
| EP-3911737-A1 | ENGINEERED ARYL SULFATE-DEPENDENT ENZYMES | Optimvia, LLC (US) | 2021-11-24 | — | — | EP | claimed |
| CN-113646427-A | Engineered arylsulfate-dependent enzymes | 奥普蒂姆维亚有限公司 | 2021-11-12 | — | — | CN | claimed |
| CN-113117080-A | Delivery of beta to brain2Methods of adrenergic receptor agonists | 珠海沅芷健康科技有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-112691088-A | Method for delivering levalbuterol to lung by inhalation of dry powder | 苏州君宁新药开发中心有限公司 | 2021-04-23 | — | — | CN | claimed |
| CN-112535668-A | A preferred method of using levalbuterol sulfate for the treatment of respiratory disorders | 苏州君宁新药开发中心有限公司 | 2021-03-23 | — | — | CN | claimed |
| CN-104069497-A | Composition and method for reducing drug tolerance and application thereof | DONGGUAN KAIFA BIOLOG MEDICINE CO LTD | 2014-10-01 | — | — | CN | claimed |
| CN-1343666-A | Monochloro-sym-triazine derivative and its application | WANG JIANGUO (CN) | 2002-04-10 | — | — | CN | claimed |
| US-5785751-A | CONTAINING CALCIUM SULFATE | CEMENT TECHNOLOGY CORPORATION (US) | 1998-07-28 | — | — | US | claimed |
| EP-0755234-A1 | COLLAGEN TREATMENT APPARATUS | LASER BIOTECH, INC. (US) | 1997-01-29 | — | — | EP | claimed |
| EP-0531537-B1 | HIRUDIN ANALOGUE OR SALT THEREOF, PRODUCTION THEREOF, AND ANTICOAGULANT CONTAINING THE SAME AS ACTIVE INGREDIENT | JAPAN ENERGY CORP (JP) | 1996-09-11 | — | — | EP | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| US-5484432-A | Collagen treatment apparatus | LASER BIOTECH, INC. (US) | 1996-01-16 | — | — | US | claimed |
| WO-1995028135-A1 | COLLAGEN TREATMENT APPARATUS | LASER BIOTECH, INC. (US) | 1995-10-26 | — | — | WO | claimed |
| US-5304169-A | Method for collagen shrinkage | LASER BIOTECH, INC. (US) | 1994-04-19 | — | — | US | claimed |
| EP-0531537-A1 | HIRUDIN ANALOGUE OR SALT THEREOF, PRODUCTION THEREOF, AND ANTICOAGULANT CONTAINING THE SAME AS ACTIVE INGREDIENT | JAPAN ENERGY CORPORATION (JP) | 1993-03-17 | — | — | EP | claimed |